IFN-γ -activated MDM MOs may contribute to the destruction or inhibition of tumor cells by releasing tumor-inhibitory molecules or by direct surface cell-to-cell interactions, such as ADCC or phagocytosis, using the Fc-γ R pathway. Here, FCGR2A is linked to neoplasm.